News

Press Releases

BlueRock Therapeutics receives FDA Fast Track Designation for OpCT-001 for the treatment of primary photoreceptor diseases 

February 27, 2025
Podcasts

Cell & Gene The Podcast: Inside BlueRock Therapeutics’ Parkinson’s Disease Trial

April 25, 2024
Podcasts

Headlines of the Future Podcast: The Future of Cell and Gene Therapies

November 22, 2023
Podcasts

Just One Question Podcast: S3 E6 – Biotech expert Seth and Nick discuss revolutionary regenerative medicine treatments

October 27, 2023
Podcasts

The Stem Cell Podcast: Ep 228 – “Developing Regenerative Medicines” Featuring Dr. Stefan Irion

October 18, 2023
Podcasts

The Cell and Gene Podcast: The Future Of iPSCs With BlueRock Therapeutics’ CEO Seth Ettenberg

December 8, 2022

Tags